ScreenerHero

TLSIWTriSalus Life Sciences Inc. Warrant

NAS · US · Healthcare · Biotechnology · trisaluslifesci.com
0.5600USD0.00%Mkt Cap: —P/E: —

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat live…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)45.08M $
Gross Profit38.19M $
Net Income (TTM)-39.23M $
Revenue/Share0.9010 USD
Last Price0.5600 USD
Fiscal Year End—
MR Quarter—
Employees102
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.68
EPS (TTM)—
EPS (Forward)—
52W Range
0.44103% of range5.000
52W High5.000 USD
52W Low0.4410 USD
Profitability
Gross Margin84.57%
Oper. Margin-86.03%
EBITDA Margin-66.44%
Profit Margin-86.88%
ROE115.85%
ROA-111.03%
Growth
Revenue Growth1.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.01M $
CapEx (TTM)918.00K $
FCF Margin-24.13%
FCF Yield—
Net Debt-11.86M $
Net Debt/EBITDA0.40
Balance Sheet
Debt/Equity-1.02
Current Ratio5.35
Quick Ratio4.72
Book Value/Sh0.2090 USD
Cash/Share0.7520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float49.50M
Insiders—
Institutions—
Technical
SMA 500.8345 (-32.9%)
SMA 2001.085 (-48.4%)
Beta0.43
S&P 52W Chg18.16%
Avg Vol (30d)2.42K
Avg Vol (10d)610
Technical Indicators
RSI (14)35.9
MACD-0.1038
MACD Signal-0.0901
MACD Hist.-0.0137
BB Upper1.163 USD
BB Middle0.8123 USD
BB Lower0.4613 USD
BB Width86.42%
ATR (14)0.1664 USD
Vol Ratio (20d)0.00x